Bostons’ Wright suspended 80 games for PEDs

The Boston Red Sox will be without Steven Wright for half of the 2019 season after MLB levied an 80-game suspension against the pitcher, MLB.com’s Mark Feinsand reported Wednesday afternoon. 

Feinsand disclosed that Wright tested positive for a performance-enhancing drug called growth hormone releasing peptide 2 (GHRP-2), which violates the MLB’s Joint Drug Prevention and Treatment Program.

Wright has spent his entire major league career with the Red Sox since being called up in 2013. Last season, he contributed to Boston’s World Series run with a 2.68 ERA in 53.2 innings pitched.

Wright defended himself against purposefully taking a performance-enhancing substance while still accepting responsibility for a positive test. “We couldn’t figure out how this substance got into my body,” Wright told Alex Speier of the Boston Globe. “But at the end of the day, it’s my responsibility. … It falls on me. … I know the truth. People close to me know I wouldn’t intentionally do this. … Unfortunately, sometimes things get into your system.”

Looking for the best online betting site? Visit Heritage Sports!

According to MassLive.com’s Chris Cotillo, Wright was notified of a failed offseason test during winter. Wright appealed and, during his appeal, informed the Red Sox. His appeal was officially denied Tuesday night.

Wright also noted to Chris Mason that being ineligible for the 2019 postseason due to his suspension “flat-out sucks,” but he still supports the league’s joint drug policy.

This is the second consecutive year Wright has been ineligible to start the season due to suspension. Wright’s 2018 season began with a 15-game suspension for violating the MLB’s domestic violence policy following an arrest in December 2017 for domestic assault against his wife. The suspension will begin at the start of the 2019 season. It also means Wright is ineligible to play in any postseason games this year.

Get all the latest Betting and Sport News updates on your social media outlets. Find us on both Facebook and Google+!